CN110679935A - 一种牛蒡人参精华膏及其制备方法 - Google Patents
一种牛蒡人参精华膏及其制备方法 Download PDFInfo
- Publication number
- CN110679935A CN110679935A CN201911037297.8A CN201911037297A CN110679935A CN 110679935 A CN110679935 A CN 110679935A CN 201911037297 A CN201911037297 A CN 201911037297A CN 110679935 A CN110679935 A CN 110679935A
- Authority
- CN
- China
- Prior art keywords
- percent
- burdock
- pollen
- ginseng
- concentrated solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000003130 Arctium lappa Nutrition 0.000 title claims abstract description 81
- 235000008078 Arctium minus Nutrition 0.000 title claims abstract description 81
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 68
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 68
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 68
- 239000006071 cream Substances 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 244000294263 Arctium minus Species 0.000 title description 2
- 244000131316 Panax pseudoginseng Species 0.000 title 1
- 240000005528 Arctium lappa Species 0.000 claims abstract description 79
- 240000004371 Panax ginseng Species 0.000 claims abstract description 67
- 239000000843 powder Substances 0.000 claims abstract description 37
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 28
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims abstract description 24
- 241000018646 Pinus brutia Species 0.000 claims abstract description 24
- 235000011613 Pinus brutia Nutrition 0.000 claims abstract description 24
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 claims abstract description 21
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 21
- 210000002969 egg yolk Anatomy 0.000 claims abstract description 21
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 20
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 20
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims abstract description 20
- 235000021307 Triticum Nutrition 0.000 claims abstract description 20
- 229940063333 burdock root extract Drugs 0.000 claims abstract description 20
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 19
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 18
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 18
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 18
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 18
- 244000134552 Plantago ovata Species 0.000 claims abstract description 18
- 235000003421 Plantago ovata Nutrition 0.000 claims abstract description 18
- 240000008042 Zea mays Species 0.000 claims abstract description 18
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 18
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 18
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 claims abstract description 18
- 235000005822 corn Nutrition 0.000 claims abstract description 18
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims abstract description 18
- 244000131360 Morinda citrifolia Species 0.000 claims abstract description 16
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 16
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims abstract description 16
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 16
- 235000012907 honey Nutrition 0.000 claims abstract description 16
- 239000010903 husk Substances 0.000 claims abstract description 16
- 235000017524 noni Nutrition 0.000 claims abstract description 16
- 244000144927 Aloe barbadensis Species 0.000 claims abstract description 15
- 235000002961 Aloe barbadensis Nutrition 0.000 claims abstract description 15
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 15
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 15
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 15
- 239000009223 Psyllium Substances 0.000 claims abstract description 15
- 235000003434 Sesamum indicum Nutrition 0.000 claims abstract description 15
- 240000003829 Sorghum propinquum Species 0.000 claims abstract description 15
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 15
- 229940070687 psyllium Drugs 0.000 claims abstract description 15
- 235000011347 Moringa oleifera Nutrition 0.000 claims abstract description 14
- 244000179886 Moringa oleifera Species 0.000 claims abstract description 14
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 14
- 235000011477 liquorice Nutrition 0.000 claims abstract description 14
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 13
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 13
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims abstract description 12
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims abstract description 12
- 241000208688 Eucommia Species 0.000 claims abstract description 10
- 235000000533 Rosa gallica Nutrition 0.000 claims abstract description 9
- 244000181025 Rosa gallica Species 0.000 claims abstract description 9
- 235000001188 Peltandra virginica Nutrition 0.000 claims abstract description 7
- 240000008620 Fagopyrum esculentum Species 0.000 claims abstract description 5
- 244000040738 Sesamum orientale Species 0.000 claims abstract 4
- 244000098338 Triticum aestivum Species 0.000 claims abstract 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 37
- 150000001875 compounds Chemical class 0.000 claims description 20
- 241000756042 Polygonatum Species 0.000 claims description 17
- 244000197580 Poria cocos Species 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 15
- 239000002245 particle Substances 0.000 claims description 14
- 238000009835 boiling Methods 0.000 claims description 13
- 102000002322 Egg Proteins Human genes 0.000 claims description 10
- 108010000912 Egg Proteins Proteins 0.000 claims description 10
- 241000220317 Rosa Species 0.000 claims description 10
- 235000013345 egg yolk Nutrition 0.000 claims description 10
- 238000005406 washing Methods 0.000 claims description 10
- 230000001954 sterilising effect Effects 0.000 claims description 8
- 239000002131 composite material Substances 0.000 claims description 6
- 235000004879 dioscorea Nutrition 0.000 claims description 5
- 238000011049 filling Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 238000001694 spray drying Methods 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 235000011330 Armoracia rusticana Nutrition 0.000 claims description 3
- 240000003291 Armoracia rusticana Species 0.000 claims description 3
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 3
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 3
- 240000008866 Ziziphus nummularia Species 0.000 claims description 3
- 238000005520 cutting process Methods 0.000 claims description 3
- 230000006378 damage Effects 0.000 claims description 3
- 229940010454 licorice Drugs 0.000 claims description 3
- 244000292697 Polygonum aviculare Species 0.000 claims description 2
- 235000006386 Polygonum aviculare Nutrition 0.000 claims description 2
- 238000005336 cracking Methods 0.000 claims 1
- 238000005057 refrigeration Methods 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 28
- 239000008280 blood Substances 0.000 abstract description 28
- 238000010521 absorption reaction Methods 0.000 abstract description 16
- 230000036039 immunity Effects 0.000 abstract description 16
- 235000016709 nutrition Nutrition 0.000 abstract description 16
- 210000002784 stomach Anatomy 0.000 abstract description 15
- 210000004556 brain Anatomy 0.000 abstract description 12
- 239000000126 substance Substances 0.000 abstract description 12
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 11
- 239000011575 calcium Substances 0.000 abstract description 11
- 229910052791 calcium Inorganic materials 0.000 abstract description 11
- 230000002829 reductive effect Effects 0.000 abstract description 10
- 206010010774 Constipation Diseases 0.000 abstract description 9
- 230000032683 aging Effects 0.000 abstract description 9
- 210000005036 nerve Anatomy 0.000 abstract description 9
- 210000000936 intestine Anatomy 0.000 abstract description 5
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 abstract description 4
- 241001633680 Polygonatum odoratum Species 0.000 abstract description 4
- 230000000840 anti-viral effect Effects 0.000 abstract description 4
- 230000003796 beauty Effects 0.000 abstract description 4
- 239000003795 chemical substances by application Substances 0.000 abstract description 3
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 63
- 239000000243 solution Substances 0.000 description 40
- 230000006870 function Effects 0.000 description 25
- 235000019197 fats Nutrition 0.000 description 19
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 17
- 230000001737 promoting effect Effects 0.000 description 17
- 241000209140 Triticum Species 0.000 description 16
- 241000219051 Fagopyrum Species 0.000 description 15
- 206010011224 Cough Diseases 0.000 description 14
- 206010028980 Neoplasm Diseases 0.000 description 14
- 201000010099 disease Diseases 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 230000002401 inhibitory effect Effects 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 13
- 210000004072 lung Anatomy 0.000 description 13
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 12
- 230000036772 blood pressure Effects 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 12
- 235000015097 nutrients Nutrition 0.000 description 12
- 239000003814 drug Substances 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- 241000207961 Sesamum Species 0.000 description 10
- 201000011510 cancer Diseases 0.000 description 10
- 230000035764 nutrition Effects 0.000 description 10
- 208000024172 Cardiovascular disease Diseases 0.000 description 9
- 150000003254 radicals Chemical class 0.000 description 9
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 8
- 235000008737 Polygonatum biflorum Nutrition 0.000 description 8
- 206010003549 asthenia Diseases 0.000 description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- 210000002216 heart Anatomy 0.000 description 8
- 235000020234 walnut Nutrition 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 240000007049 Juglans regia Species 0.000 description 7
- 235000009496 Juglans regia Nutrition 0.000 description 7
- 229930006000 Sucrose Natural products 0.000 description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 7
- 235000012000 cholesterol Nutrition 0.000 description 7
- 206010016256 fatigue Diseases 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 230000004060 metabolic process Effects 0.000 description 7
- 230000002633 protecting effect Effects 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 7
- 239000005720 sucrose Substances 0.000 description 7
- 239000013589 supplement Substances 0.000 description 7
- 230000035922 thirst Effects 0.000 description 7
- 241000186000 Bifidobacterium Species 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 239000005715 Fructose Substances 0.000 description 6
- 229930091371 Fructose Natural products 0.000 description 6
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 6
- 244000269722 Thea sinensis Species 0.000 description 6
- -1 and contains arctone Chemical compound 0.000 description 6
- 244000052616 bacterial pathogen Species 0.000 description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 206010012601 diabetes mellitus Diseases 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 229910052742 iron Inorganic materials 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- 102000019197 Superoxide Dismutase Human genes 0.000 description 5
- 108010012715 Superoxide dismutase Proteins 0.000 description 5
- 229930003268 Vitamin C Natural products 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 230000007937 eating Effects 0.000 description 5
- 230000002708 enhancing effect Effects 0.000 description 5
- 229930003935 flavonoid Natural products 0.000 description 5
- 235000017173 flavonoids Nutrition 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 239000003053 toxin Substances 0.000 description 5
- 235000019154 vitamin C Nutrition 0.000 description 5
- 239000011718 vitamin C Substances 0.000 description 5
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 244000281702 Dioscorea villosa Species 0.000 description 4
- 102000001554 Hemoglobins Human genes 0.000 description 4
- 108010054147 Hemoglobins Proteins 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 206010033557 Palpitations Diseases 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 208000026106 cerebrovascular disease Diseases 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 230000035622 drinking Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000029142 excretion Effects 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 239000000787 lecithin Substances 0.000 description 4
- 229940067606 lecithin Drugs 0.000 description 4
- 235000010445 lecithin Nutrition 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 235000001968 nicotinic acid Nutrition 0.000 description 4
- 229960003512 nicotinic acid Drugs 0.000 description 4
- 239000011664 nicotinic acid Substances 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- JPFCOVZKLAXXOE-XBNSMERZSA-N (3r)-2-(3,5-dihydroxy-4-methoxyphenyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-chromen-4-yl]-3,4-dihydro-2h-chromene-3,5,7-triol Chemical compound C1=C(O)C(OC)=C(O)C=C1C1[C@H](O)CC(C(O)=CC(O)=C2[C@H]3C4=C(O)C=C(O)C=C4O[C@@H]([C@@H]3O)C=3C=CC(O)=CC=3)=C2O1 JPFCOVZKLAXXOE-XBNSMERZSA-N 0.000 description 3
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 208000007443 Neurasthenia Diseases 0.000 description 3
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 3
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 3
- 229920001991 Proanthocyanidin Polymers 0.000 description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 208000007502 anemia Diseases 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000008468 bone growth Effects 0.000 description 3
- 208000013116 chronic cough Diseases 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 244000237330 gutta percha tree Species 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 230000000242 pagocytic effect Effects 0.000 description 3
- 238000005502 peroxidation Methods 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000002040 relaxant effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 229910052711 selenium Inorganic materials 0.000 description 3
- 239000011669 selenium Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 208000000044 Amnesia Diseases 0.000 description 2
- 208000031091 Amnestic disease Diseases 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- 206010007882 Cellulitis Diseases 0.000 description 2
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 2
- 241000190633 Cordyceps Species 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 208000035240 Disease Resistance Diseases 0.000 description 2
- 206010013789 Dry throat Diseases 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- 239000004378 Glycyrrhizin Substances 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 2
- 229920002488 Hemicellulose Polymers 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010034038 Parotitis Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 241000416918 Polyphylla Species 0.000 description 2
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 206010041497 Spermatorrhoea Diseases 0.000 description 2
- 208000012886 Vertigo Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000006986 amnesia Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 229940038481 bee pollen Drugs 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000003925 brain function Effects 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 150000002016 disaccharides Chemical class 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 230000001817 pituitary effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 229920002414 procyanidin Polymers 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 208000004124 rheumatic heart disease Diseases 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 230000036186 satiety Effects 0.000 description 2
- 235000019627 satiety Nutrition 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 230000037394 skin elasticity Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 206010044008 tonsillitis Diseases 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 231100000889 vertigo Toxicity 0.000 description 2
- 230000004382 visual function Effects 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- CWVRJTMFETXNAD-BMNNCGMMSA-N (1s,3r,4s,5r)-3-[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylic acid Chemical compound O[C@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-BMNNCGMMSA-N 0.000 description 1
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 description 1
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 1
- CUKWUWBLQQDQAC-VEQWQPCFSA-N (3s)-3-amino-4-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2s,3s)-1-[[(2s)-1-[(2s)-2-[[(1s)-1-carboxyethyl]carbamoyl]pyrrolidin-1-yl]-3-(1h-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-ox Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C1=CC=C(O)C=C1 CUKWUWBLQQDQAC-VEQWQPCFSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- HOMSOWZTBJWNHP-UHFFFAOYSA-N 5-chlorothiadiazole Chemical compound ClC1=CN=NS1 HOMSOWZTBJWNHP-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 235000017303 Althaea rosea Nutrition 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 102000005862 Angiotensin II Human genes 0.000 description 1
- 101800000733 Angiotensin-2 Proteins 0.000 description 1
- 102000004881 Angiotensinogen Human genes 0.000 description 1
- 108090001067 Angiotensinogen Proteins 0.000 description 1
- 102000015427 Angiotensins Human genes 0.000 description 1
- 108010064733 Angiotensins Proteins 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-IGMARMGPSA-N Carbon-12 Chemical compound [12C] OKTJSMMVPCPJKN-IGMARMGPSA-N 0.000 description 1
- 108090000397 Caspase 3 Proteins 0.000 description 1
- 102100029855 Caspase-3 Human genes 0.000 description 1
- 102100026550 Caspase-9 Human genes 0.000 description 1
- 108090000566 Caspase-9 Proteins 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 235000009046 Convallaria majalis Nutrition 0.000 description 1
- 244000068485 Convallaria majalis Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 206010010970 Cor pulmonale chronic Diseases 0.000 description 1
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 208000036649 Dysbacteriosis Diseases 0.000 description 1
- 208000027244 Dysbiosis Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 241000555682 Forsythia x intermedia Species 0.000 description 1
- 229920002670 Fructan Polymers 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010018901 Haemoglobinaemia Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000218033 Hibiscus Species 0.000 description 1
- 235000017881 Hibiscus moscheutos subsp moscheutos Nutrition 0.000 description 1
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 1
- 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 1
- YZJSUQQZGCHHNQ-UHFFFAOYSA-N Homoglutamine Chemical compound OC(=O)C(N)CCCC(N)=O YZJSUQQZGCHHNQ-UHFFFAOYSA-N 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102100037852 Insulin-like growth factor I Human genes 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 241000334160 Isatis Species 0.000 description 1
- 241000758791 Juglandaceae Species 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 201000010538 Lactose Intolerance Diseases 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 229930194248 Licoflavone Natural products 0.000 description 1
- MEHHCBRCXIDGKZ-UHFFFAOYSA-N Licoflavone C Natural products CC(C)=CCC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 MEHHCBRCXIDGKZ-UHFFFAOYSA-N 0.000 description 1
- FURUXTVZLHCCNA-UHFFFAOYSA-N Liquiritigenin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-UHFFFAOYSA-N 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 240000000233 Melia azedarach Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 102000043276 Oncogene Human genes 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 201000002451 Overnutrition Diseases 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 101710184309 Probable sucrose-6-phosphate hydrolase Proteins 0.000 description 1
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 206010040840 Skin erosion Diseases 0.000 description 1
- 241000209072 Sorghum Species 0.000 description 1
- 102400000472 Sucrase Human genes 0.000 description 1
- 101710112652 Sucrose-6-phosphate hydrolase Proteins 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010042682 Swelling face Diseases 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 102000046299 Transforming Growth Factor beta1 Human genes 0.000 description 1
- 101800002279 Transforming growth factor beta-1 Proteins 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229950006323 angiotensin ii Drugs 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000037180 bone health Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 208000023819 chronic asthma Diseases 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000026636 chronic pulmonary heart disease Diseases 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 1
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 1
- 239000000490 cosmetic additive Substances 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000007140 dysbiosis Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000000235 effect on cancer Effects 0.000 description 1
- 230000000225 effect on diabetes Effects 0.000 description 1
- 230000002888 effect on disease Effects 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000021001 fermented dairy product Nutrition 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 239000005452 food preservative Substances 0.000 description 1
- 235000019249 food preservative Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 235000019525 fullness Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 230000008991 intestinal motility Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- KRZBCHWVBQOTNZ-DLDRDHNVSA-N isochlorogenic acid Natural products O[C@@H]1[C@H](C[C@@](O)(C[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)C(=O)O)OC(=O)C=Cc3ccc(O)c(O)c3 KRZBCHWVBQOTNZ-DLDRDHNVSA-N 0.000 description 1
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- FURUXTVZLHCCNA-AWEZNQCLSA-N liquiritigenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-AWEZNQCLSA-N 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 229940041667 oral paste Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 235000020823 overnutrition Nutrition 0.000 description 1
- VDYCLYGKCGVBHN-UHFFFAOYSA-N pachymaic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)C(O)CC21C VDYCLYGKCGVBHN-UHFFFAOYSA-N 0.000 description 1
- SRDNLMOBFKJOSD-UHFFFAOYSA-N pachymic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C(O)=O)C(O)CC21C SRDNLMOBFKJOSD-UHFFFAOYSA-N 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920001197 polyacetylene Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 208000017497 prostate disease Diseases 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000007180 rose mallow Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- TUGDLVFMIQZYPA-UHFFFAOYSA-N tetracopper;tetrazinc Chemical compound [Cu+2].[Cu+2].[Cu+2].[Cu+2].[Zn+2].[Zn+2].[Zn+2].[Zn+2] TUGDLVFMIQZYPA-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000009916 yin-huang Substances 0.000 description 1
- 239000009792 yinqiao Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L15/00—Egg products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
- A23L21/25—Honey; Honey substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种牛蒡人参精华膏及其制备方法,本发明将牛蒡根提取物作为主要原料,富含人参浓缩液、水解蛋黄粉、蜂蜜、库拉索芦荟凝胶、诺丽果浆、小麦低聚肽、圆苞车前子壳、壳寡糖、L‑阿拉伯糖、低聚异麦芽糖、山药、茯苓、重瓣红玫瑰、松花粉、金银花、玉米花粉、芝麻花粉、高粱花粉、荞麦花粉、菜花粉、玉竹、桃仁、红枣、桂圆、甘草、蛹虫草、杜仲雄花、辣木叶、阿萨伊果,制成牛蒡精华膏;制备方法简单,制得的牛蒡精华膏作为口服营养剂,由于含有水解蛋黄粉,可以促进人体对钙物质的吸收,可以提高人体免疫力以及抗病毒的能力,改善肠胃、治疗便秘、改善睡眠、补血安神、健脑益智,还可以美容养颜、美容瘦身、抗衰老、改善暗黄肤质。
Description
技术领域
本发明涉及一种牛蒡膏,具体是一种牛蒡人参精华膏及其制备方法,属于营养食品加 工技术领域。
背景技术
牛蒡为菊科2-3年生草本植物,在我国种植历史较久,在江苏、山东一带有大量的种 植,作为特色农副产品,大量出口日本、韩国和东南地区。牛蒡肉质根,具有苦辛味,并有特殊风味,含有许多人体必需的营养物质。
目前常见的口服膏状物有枇杷膏,可以润肺止咳,梨膏可以止咳化痰等,没有牛蒡膏, 但是由于牛蒡根富含营养丰富,每百克鲜根含蛋白质4.70g、脂肪0.80g、碳水化合物3g、 粗纤维2.40g、灰分2.40g、维生素Bl0.02mg、维生素B22.29mg、尼克酸1.10mg、维生素C25.00mg、钙242.00mg、磷61.00mg、铁7.60mg,还含有牛蒡酮、醇、绿原素、异绿原素、 咖啡酸及其衍生物等,只将牛蒡用在牛蒡糖、牛蒡罐头等其他常见食品确实是丧失的牛蒡 的很多功能,所以将牛蒡根用作精华膏的主要成分将会是牛蒡产品的一个新突破。
发明内容
针对上述现有技术存在的问题,本发明提供一种牛蒡人参精华膏及其制备方法,制备 方法简单,将牛蒡根作为主要原料,制成牛蒡精华膏,制得的牛蒡精华膏作为口服营养剂, 食用后可以提高人体免疫力以及抗病毒的能力,还可以美容养颜、抗衰老、改善暗黄肤质。
为了实现上述目的,本发明采用的技术方案是:一种牛蒡人参精华膏,该精华膏由以 下质量百分比的原料组成:牛蒡根提取物50~55%、人参浓缩液5~6%、复合浓缩液5~6%、 水解蛋黄粉5~6%、蜂蜜5~6%、库拉索芦荟凝胶5~6%、诺丽果浆5~6%、小麦低聚肽5~ 6%、圆苞车前子壳5~6%、壳寡糖5~6%、L-阿拉伯糖5~6%、低聚异麦芽糖8~10%,其中 复合浓缩液包括山药0.5~0.55%、茯苓0.4~0.45%、重瓣红玫瑰0.3~0.35%、松花粉0.2~ 0.25%、金银花0.2~0.25%、玉米花粉0.22~0.3%、芝麻花粉0.5~0.55%、高粱花粉0.25~0.3%、荞麦花粉0.3~0.35%、菜花粉0.15~0.2%、玉竹0.1~0.15%、桃仁0.25~0.3%、 红枣0.5~0.55%、桂圆0.12~0.2%、甘草0.25~0.3%、蛹虫草0.1~0.15%、杜仲雄花0.4~ 0.43%、辣木叶0.1~0.15%、阿萨伊果0.16~0.22%。
优选的,该精华膏由以下质量份的原料制成:牛蒡根提取物52.5%、人参浓缩液5.5%、 复合浓缩液5.5%、水解蛋黄粉5.5%、蜂蜜5.5%、库拉索芦荟凝胶5.5%、诺丽果浆5.5%、 小麦低聚肽5.5%、圆苞车前子壳5.5%、壳寡糖5.5%、L-阿拉伯糖5.5%、低聚异麦芽糖9%, 其中复合浓缩液包括山药0.52%、茯苓0.43%、重瓣红玫瑰0.33%、松花粉0.23%、金银花 0.23%、玉米花粉0.26%、芝麻花粉0.53%、高粱花粉0.28%、荞麦花粉0.33%、菜花粉0.18%、 玉竹0.13%、桃仁0.28%、红枣0.53%、桂圆0.17%、甘草0.28%、蛹虫草0.13%、杜仲雄花 0.42%、辣木叶0.13%、阿萨伊果0.19%。
牛蒡根提取物通过以下步骤制得:精选二年生新鲜牛蒡根,剔除腐烂、虫蛀、霉变干 裂不合格品,将合格的牛蒡根使用前放在2~8℃冷库中贮存3~6个月,取出牛蒡根,用清 水冲洗,将洗净的牛蒡根去皮,将去皮后的牛蒡根切粒,将切粒后的牛蒡根颗粒加水预煮 熬制30~50min,再进行喷雾干燥做成速溶颗粒粉;牛蒡根颗粒与水的比例为1:10。
人参浓缩液通过以下步骤制得:精选人参,将精选后的人参用清水冲洗,冲洗后的人 参切片,人参片中加水按照1:10的比例,预煮熬制浓缩,浓缩至1:1的比例备用。
复合浓缩液通过以下步骤制得:按配比分别秤取山药、茯苓、重瓣红玫瑰、松花粉、金银花、玉米花粉、芝麻花粉、高粱花粉、荞麦花粉、菜花粉、玉竹、桃仁、红枣、桂圆、 甘草、蛹虫草、杜仲雄花、辣木叶、阿萨伊果,混合后加水按照1:10的比例,预煮熬制剩 余比例为1:1备用。
一种牛蒡人参精华膏的制备方法,包括以下步骤:
S1、将牛蒡根提取物、人参浓缩液、复合浓缩液混合,得到混合浓缩液;
S2、在步骤S1中的混合浓缩液中加入水解蛋黄粉、蜂蜜、库拉索芦荟凝胶、诺丽果浆、 小麦低聚肽、圆苞车前子壳、壳寡糖、L-阿拉伯糖、低聚异麦芽糖,混合后,继续熬制,直至固形物含量为70~90%,结束熬制,得到精华膏;
S3、将熬制好的精华膏进行热灌装后杀菌,杀菌温度为80~90℃,时间为25~35min。
本发明中各成分作用如下:
牛蒡根:牛蒡根主要含硫炔类、多炔类、多酚类、挥发油、菊糖以及氨基酸等化学成分;药理活性主要有抗菌、抗突变、防癌、抗氧化、抗疲劳、降血糖、降血脂和免疫调节 等;主治:祛风热,消肿毒。治风毒面肿,头晕,咽喉热肿,齿痛,咳嗽,消渴,痈疽疮 疥。
人参:人参的主要成分为人参皂、人参活素、少量挥发油、各种氨基酸和肽类、葡萄糖、果糖、果胶以及维生素B1、B2、烟酸、泛酸等。人参的营养成分可以被皮肤缓慢吸收、 对皮肤没有任何的不良刺激,能扩张皮肤的毛细血管,促进皮肤血液循环,增强皮肤营养, 防止皮肤脱水,硬化、起皱,从而增强了皮肤的弹性,使细胞得到新生,对保护皮肤光洁 和滋润,防止过早衰老,起到美容作用。人参的肉质根为著名强壮滋补药,适用于调整血 压、恢复心脏功能、神经衰弱及身体虚弱等症,也有祛痰、健胃、利尿、兴奋等功效,药 理活性主要有大补元气、补五脏、益元气、通血脉、生津止渴、安神益智等功效;主治劳 伤虚损、厌食、劳累、反胃吐食、大便滑泄、虚咳喘促、自汗暴脱、惊悸、健忘、眩晕头 痛、阳痿、尿频、消渴、妇女崩漏、小儿慢惊及身体虚弱,一切气血津液不足的症状。尤 其在抢救休克病人的时候,可以发挥重要的作用,并且对糖尿病、心律失常、脑血管病、 高血脂和消化不良也有一定的治疗作用,由于人参可以提高免疫力,因此对癌症患者也有 作用。
水解蛋黄粉:水解蛋黄粉就是提取自鸡蛋黄的一种的功能性物质,通过刺激骨芽细胞, 促进骨骼增长因子(IGF1、TGFβ1)的产生,其结果就是促进骨骼的成长;水解蛋黄粉通过抑 制破骨细胞的细胞分裂因子的分泌(如:IL-1、IL-6、TNFα),维持骨骼成分的平衡。水解蛋 黄粉能够促进钙的吸收,同时抑制钙的过度流失,从而促进骨骼的成长和健康。
蜂蜜:蜂蜜本身属于甜、偏黏性、未干的一种物质,对脾胃有很好的保护作用,也具有 润肠通便的功效,尤其是针对气虚、便秘的老年人。同时清热,补中,润燥,止痛,解毒,减肥的作用。
库拉索芦荟凝胶:芦荟凝胶冻干粉在滋润干燥肌肤、祛斑除痘、削除皱纹、恢复皮肤 弹性,提高人体免疫力,清除自由基,缓解发炎和受损皮肤的疼痛等方面有着独特神奇的 功效。
诺丽果浆:诺丽果浆是一种含有果肉的混浊液体,具有很好的改善肠胃的作用,对于 肠胃不好的人们来说,饮用这种饮品后可以帮助消化和吸收,解决便秘、营养不吸收、消化不良的问题。同时还可以改善我们的睡眠问题,适合经常失眠、睡眠质量低、晚上睡不 着以及白天没有精神无法集中注意力的人群使用。除此之外还可以延缓人们的衰老,实现 人体的快速新陈代谢,提亮我们的肤色。
小麦低聚肽:有抑制胆固醇上升的作用,小麦低聚肽能促进胰岛素分泌作用,其功能 物质是低聚蛋氨酸,可用于调节人的血糖,改善糖尿病症状。小麦肽能阻碍血管紧张素酶 的作用,因而有降血压作用。小麦低聚肽的特点之一是含高谷酰胺,能够有效调节神经,也可作肠功能障碍时的特殊营养物质;具有ACE抑制作用、免疫调节、抗氧化等多种生物 活性,能够刺激机体淋巴细胞增殖,增强巨噬细胞吞噬功能,提高机体抵御外界病原体感 染的能力,降低机体发病率等;小麦低聚肽是小麦蛋白酶解产物,能抑制血管紧张素转化 酶的活性,使血管紧张素原不能转变成能使血压升高的血管紧张素Ⅱ,从而生理地降低血压,而对正常血压不起用;抗氧化活性;调节免疫;抑制凋亡。
圆苞车前子壳:圆苞车前子壳中的纤维主要由半纤维素组成,这种半纤维素是一种复 合的碳水化合物,广泛存在于谷物、水果和蔬菜中。半纤维素不能轻易地被人体消化,但 是可以在结肠内部分解,并有益于肠内益生菌的形成;圆苞车前子壳粉是一种纯天然植物 纤维的重要来源,可吸水膨胀50倍左右,形成果冻状的黏稠物质,有“陆上胶质之王”的美称,所以很多女生喜欢食用洋车前子壳粉来补充胶质,并且达到美容瘦身的功效。
壳寡糖:壳寡糖具有提高免疫,抑制癌肿细胞生长,促进肝脾抗体形成,促进钙及矿 物质的吸收,增殖双歧杆菌、乳酸菌等人体有益菌群,降血脂、降血压、降血糖、调节胆固醇,减肥,预防成人疾病等功能,可应用于医药、功能性食品等领域。壳寡糖可明显消 除人体氧负离子自由基,活化机体细胞,延缓衰老,抑制皮肤表面有害菌滋生,保湿性能 优异,是日化领域的基础原料。壳寡糖不但具备水溶性,使用方便,而且抑制腐败菌性能 效果显著,兼备多种功能作用,是性能优良的天然食品防腐保鲜剂。
L-阿拉伯糖:L-阿拉伯糖在食品和药品方面的使用功能主要有两项,一是能抑制水解 双糖的酶,因此抑制因摄入蔗糖(在小肠蔗糖酶的作用下分解成葡萄糖和果糖而被吸收)而 导致的血糖升高;简称抑制双糖水解的降糖作用。二是因L-阿拉伯糖对双糖水解酶的抑制作 用,使在小肠里没被分解的蔗糖在大肠里被微生物分解产生出大量的有机酸,这种有机酸 对肝脏合成脂肪有抑制作用,再加上L-阿拉伯糖在小肠里对吸收蔗糖的抑制作用,从而减 少体内新脂肪的产生。L-阿拉伯糖可以与蔗糖配伍使用也可单独食用。在蔗糖中加入3.5% 的比例,能够抑制人体60-70%蔗糖的吸收,长期使用可以降低血糖。单独食用L-阿拉伯糖, 效果相同。
低聚异麦芽糖:促进食物消化、吸收,维持肠道正常功能;恢复抗菌素治疗、放射线治疗、化学治疗期间肠道正常菌落;改善腹泻与便泌,抑制病原菌和腐败菌。服用低聚异 麦芽糖能降低病原菌量,故对腹泻有预防和治疗效果。由于低聚异麦芽糖能导致双歧杆菌 增殖,双歧杆菌通过糖代谢相应增加丙酸、丁酸等酸分泌量,这些有机酸促进肠道蠕动, 使肠道运动亢进,同时通过渗透压增加粪便水分,从而使排便性状得到改善。长期食用低 聚异麦芽糖,能防止和治疗便秘;提高机体免疫力,起到免疫调节剂作用;减少肠道致癌 物质,改善血清脂质,降低胆固醇含量;营养素吸收促进作用和产生营养素。双歧杆菌能 产生维生素B1、维生素B2、维生素B6、维生素B12、烟酸、叶酸,含双歧杆菌发酵乳制品 能改善乳糖不耐症、及对钙吸收。双歧杆菌对矿物质元素有促进吸收作用,女性育龄期后 雌激素水平下降,使体内钙平衡受到干扰,导致骨质疏松;而雌激素水平下降又与肠内菌 群失调有关。
山药:可以预防心血管疾病。冬季,室内温差比较大,加上气温普遍较低,是心血管疾病病发的高峰季之一,而山药含有大量的黏液蛋白、维生素及微量元素,能有效阻止血脂在血管壁的沉淀,预防心血疾病,有降血压、安稳心神的功效,很适合在冬季吃。可以 健脾益胃、助消化。冬季运动量会不自觉地减少,加上因为气温降低,新陈代谢的数率降 低,加上冬季吃火锅的频率增多,会使得患上肠胃病的几率增多。薯蓣含有淀粉酶、多酚 氧化酶等物质,有利于脾胃消化吸收功能,是一味平补脾胃的药食两用之品。不论脾阳亏 或胃阴虚,皆可食用。临床上常与胃肠饮同用治脾胃虚弱、食少体倦、泄泻等病症,所以 冬季煲汤、吃火锅不妨加入薯蓣这一材料。可以益肺止咳。冬季干燥,寒冷,对肺部和喉 咙的伤害比较大,在冬季人们很容易会喉咙干燥甚至疼痛,薯蓣含有皂甙、黏液质,这两 种成分都有润滑,滋润的作用,所以可益肺气,养肺阴,治疗肺虚、痰嗽、久咳等症状。
茯苓:宁心安神,败毒抗癌,药性平和,利湿而不伤正气,适量服食可作为春夏潮湿季节的调养佳品;可治小便不利、水肿胀满、痰饮咳逆、呕逆、恶阻、泄泻、遗精、淋浊、 惊悸、健忘等症;所含茯苓酸具有增强免疫力、抗肿瘤以及镇静、降血糖等的作用;可松 弛消化道平滑肌,抑制胃酸分泌,防止肝细胞坏死,抗菌等功效。
重瓣红玫瑰:重瓣红玫瑰是常见的植物,也是常见的中药,虽然在平时很不起眼,可 是营养价值是很高的,首先味道甜甜的,带有玫瑰香和玫瑰花的营养成分,很多人会拿来 做保健品,食用玫瑰花可以活血化瘀,促进消化,治疗肿痛,对身体有很多的好处。
松花粉:护肤与美容,松花粉含有丰富的氨基酸和全部天然维生素以及多种酶,能增强 皮肤代谢,增加皮肤弹性,延缓皮肤衰老。维生素C、E和B族维生素协调作用,能够活化细胞,清除自由基,阻断黄褐斑、蝴蝶斑的产生,消除皮肤黑色素,减少、去除青春痘, 使得皮肤洁白美丽;同时,对亮发秀发也有较好的效果;松花粉对皮肤疾患有很好的治疗 作用。未破壁的松花粉有很强的吸水性,可燥湿收敛止血,外用可祛风止血、爽身消炎, 对皮肤无刺激、无过敏等副作用;对湿疹、黄水疮、皮肤糜烂、浓水淋漓、外伤出血、尿 布性皮炎等有很好的治疗作用。尤其用于婴幼儿童护肤爽身,防治小儿皮肤湿疹,疗效佳、 见效快。松花粉防治老年人皮肤瘙痒疗效显著,也可防治褥疮;抗衰老,松花粉所含微量元 素、黄酮类、精氨酸、维生素C、E、胡萝卜素及硒等,均有清除体内自由基作用,可提高 机体抗氧化酶类(如铜锌超氧化物歧化酶等)的活性,抑制脂质过氧化反应,消除老年斑, 延缓细胞衰老。松花粉使人返老还童的原因还在于,其多样化的活性营养物质相互作用, 调整全身功能,保持机体组织青春活力,使智力聪颖不衰,从而延缓衰老,增加寿命;抗 疲劳,松花粉可直接补充营养,也可通过改善消化功能,从食物中摄取营养,为身体补充能 量,增加耐力,使之不易疲劳。松花粉还能调整神经系统,缓解精神和工作压力,解除各 种负担造成的以及中老年人的易疲劳。松花粉可降低体内乳酸水平,适合加班工人、备考 学生、赛前运动员等劳动强度大、脑力劳动重者服用;控制体重,松花粉营养平衡,富纤维 而低热量,所含脂肪酸中72.5%为不饱和脂肪酸,与维生素E协同作用,可双向调节人体胆 固醇,使肌肉结实、体态匀称。松花粉中的纤维素含量高达29%,它一方面能产生饱腹感, 减少食物摄入,避免营养过剩;一方面又在脂肪代谢过程中抑制和延缓胆固醇与甘油三酯 在淋巴中的吸收;同时,纤维素能促进肠道功能,加快粪便排泄,解放军总医院与德国合 作进行的研究与实验证实,松花粉使粪便中胆固醇排泄量增加0.8倍,甘油三脂排泄量增 加2倍,从碳12到碳22的十余种脂肪酸排泄量最多增加约7倍。松花粉中的卵磷脂还加 速体内脂肪的燃烧,它的利尿特性也有助于减肥;心脑血管养护,心脑血管疾病是体内脂质 代谢失衡,血脂和胆固醇含量过高所致。
金银花:金银花自古以来就以它的药用价值广泛而著名,其功效主要是清热解毒,主 治温病发热、热毒血痢、痈疽疔毒等,金银花性寒,味甘,入肺、心、胃经,具有清热解 毒、抗炎、补虚疗风的功效,主治胀满下疾、温病发热,热毒痈疡和肿瘤等症。其对于头 昏头晕、口干作渴、多汗烦闷、肠炎、菌痢、麻疹、肺炎、乙脑、流脑、急性乳腺炎、败 血症、阑尾炎、皮肤感染、痈疽疔疮、丹毒、腮腺炎、化脓性扁桃体炎等病症均有一定疗 效;金银花藤煲水后对小孩湿疹等皮肤瘙痒有一定治疗作用,对畜禽的多种至病的病菌、 病毒有抑制作用,在动物饲养过程中若能添加一定剂量的金银花藤叶(忍冬藤)粉或煲水, 对预防和治疗动物的温病发热、风热感冒、咽喉炎症、肺炎、痢疾、肿溃疡、丹毒、蜂窝 组织炎等症均有相当好的作用。用连翘,板蓝根煎金银花汤可以治疗腮腺炎;金银花茶可 以祛暑明目;连翘金银花凉汤可治疗外感发热咳嗽。同时将金银花、菊花、桔梗和甘草加 水煮沸10分钟,侯凉,当饮料饮用,可治疗咽喉炎和扁桃体炎;已生产的金银花制剂有“银 翘解毒片”、“银黄片”、“银黄注射液”等。“金银花露”是金银花用蒸馏法提取的芳 香性挥发油及水溶性溜出物,为清火解毒的良品,可治小儿胎毒、疮疖、发热口渴等症; 暑季用以代茶,能治温热痧痘、血痢等。茎藤称“忍冬藤”,也供药用。金银花的有效成 份为绿原酸和异绿原酸。这是植物代谢过程中产生的次生物质,其含量的高低不仅取决于 植物的种类,而且可能在很大程度上受气候、土壤等生态、地理条件以及物候期的影响; 金银花茶有独特的减肥功能,还能抑制与杀灭咽喉部的病原菌,对老人和儿童有抗感染功 效。经常服用金银花浸泡或煎剂有利于风火目赤、咽喉肿痛、肥胖症、肝热症和肝热型高 血压的治疗与康复。
玉米花粉:玉米花粉能促进脾脏、骨骼、淋巴结和胸腺免疫器官的发育,增强免疫细 胞的活性,提高机体对抗细菌和病毒的能力;并有抗辐射、抗癌作用;同时玉米花粉能提供人体所需的多种营养成份,对于因缺少某种营养所引起的疾病,亦有良好的辅助疗效;因此玉米花粉在临床上有广泛的应用,并作为多种疾病的补充治疗品和日常营养的补充品。
芝麻花粉:止血行痢,清肿止痛,有强心作用,可作神经系统平衡剂和止痛剂;还有健胃、降血压、降血脂、美容之功效。
高粱花粉:高粱花粉具有提高免疫功能、抑瘤、防治心脑血管疾病效果。
荞麦花粉:保护毛细血管:荞麦花粉中所含的芸香苷含量较高,它对毛细血管壁具有 很强的保护作用,可防治流血和出血;还能增强心脏的收缩,使心跳速度放慢,用于心悸、 心脏衰弱、贫血和毛细血管脆弱等病症;防治心血管疾病:荞麦花粉中的黄酮类化合物能 有效清除血管壁上脂肪的沉积,从而起软化血管和降血脂的作用;长期食用花粉可以防治 动脉粥样硬化、高血压、脑溢血、静脉曲张等心血管疾病;美容减肥:荞麦花粉中的VE、超氧化歧化酶(SOD)、硒等成分能滋润营养肌肤,恢复皮肤的弹性和光洁;同时,花粉中的卵磷脂可燃烧过剩的脂肪,达到减肥的目的;补血安神:荞麦的花粉具有和硫酸亚铁相似的抗缺铁性贫血作用,能够有效改善女性贫血正常人体内红细胞数、血红蛋白浓度以及红细胞比积维持在一定正常范围内;调节肠胃:荞麦花粉对胃肠功能紊乱、溃疡病、便秘也 有良好的治疗作用;既能增进食慾又能增强消化功能,对于胃口不佳、消化吸收力差的消 瘦症能有效地康复。
菜花粉:增强免疫力,花粉多糖能激活巨噬细胞的吞噬活动,提高人体抗病能力,抵 制外来病菌的潜入;防衰老、美容,蜂花粉属营养性的美容化妆品,花粉中的ve、超氧化歧化酶(sod)、硒等成分能滋润营养肌肤,恢复皮肤的弹性和光洁,花粉中的肌醇可使白 发变黑,脱发渐生,保持头发乌黑亮丽,使人皮肤细嫩,充满青春活力;防治脑心血管疾 病,花粉中的黄酮类化合物能有效清除血管壁上脂肪的沉积,从而起软化血管和降血脂的 作用;防治前列腺疾病花粉是前列腺炎的克星;减肥,服用蜂花粉可以吸收足够的营养, 造成饱食感,同时,花粉中的卵磷脂可燃烧过剩的脂肪,达到减肥的目的。
玉竹:治疗风湿性心脏病,玉竹粘多糖、玉竹果聚糖等,有改善心肌缺氧和肾上腺皮质 激素样作用,玉竹含有的甾甙,对心肌的作用与铃兰制剂类似,增强心脏肌肉的活力,玉竹 配糖体对离体蛙心有强心作用,玉竹煎剂的作用与玉竹配糖体类似,因此,玉竹对心悸、 心绞痛,风湿性心脏病、冠状动脉粥样硬化性心脏病、肺原性心脏病引起的心力衰竭有一 定疗效;延缓衰老,玉竹中含有较多的维生素A和维生素C,具有强效的抗氧活作用,能有效的消除机体内部的自由基,对皮肤的衰老有很好的延缓效果,起到一定的美容养颜效果;滋阴润肺,玉竹在中药里主要当做生津止渴的药物,玉竹能止燥咳、劳嗽、热病阴液耗伤 之咽干口渴,对内热消渴、阴虚外感、头昏眩晕、筋脉挛痛等也有很好的治疗效果,主治 肺阴虚所致的干咳少痰,咽舌燥和温热病后期,或因高烧耗伤津液而出现的津少口渴,食 欲不振,胃部不适等症;降压作用;增强免疫力。
核桃:健脑益智,核桃含有丰富的亚油酸及DHA,是大脑和视觉功能发育所必须的营养 成份;其含有的微量元素锌、锰等都是大脑中脑垂体的重要成分。经常食用核桃能够补充 大脑所需的营养,起到健脑益智的作用;抗衰老,核桃含有丰富的亚油酸及DHA,是大脑和 视觉功能发育所必须的营养成份;其含有的微量元素锌、锰等都是大脑中脑垂体的重要成 分,经常食用核桃能够补充大脑所需的营养,起到健脑益智的作用;防便秘:核桃中含有 丰富的维生素E,维生素E是医学界公认的抗衰老物质。它能够消除身体中的自由基,帮助 身体细胞免受自由基的损害,保持细胞的活力;降血糖:核桃中含有的大量不饱和脂肪酸, 能有效减轻身体对于胰岛素的抵抗,同时对于2型糖尿病的风险能够起到降低预防的作用; 经常吃核桃能够有效降低身体血糖含量。
红枣:预防贫血,红枣中富含铁元素,而铁元素是合成血红蛋白的必需元素,如果铁 元素摄入不足会出现头晕等缺铁性贫血症状,所以常吃红枣对于旺盛生长中的青少年和女 性防治贫血有着重要作用;增强体质,红枣中富含蛋白质、脂肪、糖类、有机酸、维生素A、 维生素C、多种微量钙以及氨基酸等丰富的营养成份,适宜体弱人群食用以增强体质,女性 产后食用红枣,能补中益气、养血安神,加快机体复原,年老体弱者食用红枣,能延缓衰老,增强体质,尤其是一些从事脑力劳动及神经衰弱的人,用红枣代茶常饮,能宁心安神,增进食欲,嗜好饮茶的人如果晚间过饮.难免辗转不眠,若每晚以红枣煎汤代茶,可免除 失眠之苦;提高免疫力,红枣含有大量的糖类物质,主要为葡萄糖,也含有果糖、蔗糖, 以及由葡萄糖和果糖组成的低聚糖、阿拉伯聚糖及半乳醛聚糖等;井含有大量的维生素C、 维生素B2、硫胺素、胡萝卜素、烟酸等多种维生素,具有较强的补养作用,能提高人体免 疫功能,增强抗病能力;保护肝脏,红枣能促进白细胞的生成,降低血清胆固酵,提高血 清白蛋白,保护肝脏;现代药理发现,红枣有提高体内单核吞噬细胞系统的吞噬功能,有 保护肝脏,则增强体力的作用。
桂圆:益智补脑,桂圆中含有丰富的蛋白质、脂质、果糖、葡萄糖、钙、磷、铁多种 维生素,对脑细胞特别有益,适当食用可以增强记忆,非常适用于生长发育时期的儿童, 对于记忆力减退的老年人同样适用;安神保健,由于桂圆中含有葡萄糖、果糖和维生素B 族等维生素以及多种矿物质,可以起到安神保健的功效,特别适合于劳心伤神,容易失眠 的人群食用;补气养血,桂圆含有大量的葡萄糖、蛋白质和铁质,可以促进骨髓对血红蛋 白的合成,增加血液总量,常吃桂圆有促进造血的功效,可以用于治疗气血亏损。
甘草:甘草属中药的补益药类,为豆科多年生草本植物。其根及茎,性甘平,归心、肺、脾、胃经,主要有益气健脾、清热解毒、祛痰止咳、缓急止痛、缓和药性等作用。现 代药理研究表明:甘草含甘草甜素、甘草黄酮类化合物甘草贰、甘草甙元及天冬酞胺、甘露 醇等。甘草黄酮在美容化妆品中有多种功效。甘草是一种很好的美容添加剂,在抑制细胞 黑色素的形成、抑制酪氨酸酶的活性、抗氧化方面的效果很好,可以用于化妆品中,兼有 美白和抗衰老作用。
蛹虫草:扶正益气,蛹虫草既能补肺阴,又能补肾阳,主治肾虚,阳萎遗精,腰膝酸痛,病后虚弱,中医认为其起扶正益气作用,对老年性慢性支气管炎、肺原性心脏病有显 著疗效,能提高肝脏解毒能力,起护肝作用,提高身体抗病毒和抗辐射能力;补肺平喘, 蛹虫草味甘,性温,入肺、肾二经,有补肺平喘的功效。而且蛹虫草所含的虫草素,对结 核杆菌等引起肺部感染的病菌有强烈抑制和杀灭作用,且虫草酸和虫草多糖能修复已受损 的肺泡细胞;适用于肺结核、老人衰弱之慢性咳嗽气喘;改善调节心脑系,蛹虫草不仅具 有特殊的营养价值,而且有明显的药用价值,其所含的虫草酸是治疗心脑血管疾病的基本 药物,具有清除自由基、扩张血管、降低血压的作用,能预防治疗脑血栓、脑溢血,对改 善调节心脑系统非常有效;抗癌,虫草多糖是一种高度分枝的半乳甘露聚糖,它能促进淋 巴细胞转化,提高血清IgG的抗体含量和机体的免疫功能,增强机体自身抗癌抑癌的能力, 而SOD(超氧化物歧化酶)可以消除机体内超氧自由基,具有抗衰老、抗癌抑癌的作用,所 以,蛹虫草拥有独特的抗癌功效。
杜仲雄花:杜仲雄花具有镇静安神、保肝护肝、滋阴补肾、润肠通便的功效。可用于治疗脚气肠炎、小儿积风。长期服用还可以改善睡眠、神经衰弱、神经官能症。它含有人 体所必需的胶原蛋白,能够促进人体肌肉发达、抗疲劳、抗衰老、改善四肢无力、腰膝酸 软、还有降血压的作用。能预防冠状动脉硬化、冠心病、心绞痛、心肌缺血、心律失常、 心跳加速。
辣木叶:辣木叶粉有降血糖、降脂、降压、抗肿瘤、抗氧化、通便、利尿、驱虫、改 善睡眠等功效,长期食用可增强人体免疫功能,延缓衰老、预防疾病;经常食用辣木叶可 增强免疫力、排毒、塑身、抗老化、抗癌、并对多种慢性及重大疾病都有极大的改善功效; 辣木叶是纯天然绿色食品,含有人体所需的全部营养物质,它可取代复合维生素、钙片、 鱼肝油等,特别对高血压、高血脂、糖尿病、痛风等有很好的效果;辣木叶可协助改善、 预防疾病,改善睡眠、增强记忆力、延缓衰老,还可用来治疗肝脏、脾脏、经络等特殊部 位的疾病;它还具有治疗口臭和醒酒等作用。
阿萨伊果:抗氧化的功能,原花青素的抗氧化功能主要是通过两个方面,一方面体现 在可以抵抗脂质体体系的过氧化作用,一方面可以通过螯合金属离子实现过氧化的作用。 例如,原花青素可以减少由自由基引发剂诱导的肝脂肪过氧化作用;增强免疫力,阿萨伊 含有全世界最强的抗氧化剂和生物类黄硐素,抵御致癌基因的侵袭,唤醒自身免疫力。美 国佛罗里达大学的一项测试中,阿萨伊提取物触发了86%的白血病癌细胞的自毁机制,可有 效的抑制癌症的发生;预防心血管疾病的功能,三酰甘油是导致粥样硬化的危险因素,要 想降低油脂的生成与吸收,就需要降低胰脂活性酶的活力,原花青素中的二聚体可以有效 抑制胰脂活性酶的活性,起到降血脂的作用;抗糖尿病以及其引发的综合症状,原花青素 可以降低糖尿病大鼠的血糖水平,降低血液中血清总胆固醇、甘油三酯和低密度脂蛋白的 水平,原花青素提取物可以改善糖尿病大鼠主动脉的功能,减少主动脉内膜损伤;抗炎的 功能,原花青素可以有效的减缓由炎症因子所引起的毛细血管通透性的增强,增加血管细 胞壁的弹性,来保证局部毛细血管的运转能力,达到消炎的目的;抗肿瘤的功能,原花青 素可抑制肺癌细胞中半胱天冬酶-9、半胱天冬酶-3蛋白的表达,抑制癌细胞增殖,促进癌 细胞凋亡,起到抗肿瘤的作用;抗疲劳的功能,原花青素可以提高大鼠的负重游泳时间, 减少体内乳酸的含量。试验研究表明,原花青素可以提高大鼠体内血红蛋白的含量,因此 有利于运动过程中向机体提供更多的氧,加强有氧代谢的供能,减少乳酸的产生,从而减 轻疲劳感。
与现有技术相比,本发明将牛蒡根提取物作为主要原料,富含人参浓缩液、水解蛋黄 粉、蜂蜜、库拉索芦荟凝胶、诺丽果浆、小麦低聚肽、圆苞车前子壳、壳寡糖、L-阿拉伯糖、低聚异麦芽糖、山药、茯苓、重瓣红玫瑰、松花粉、金银花、玉米花粉、芝麻花粉、 高粱花粉、荞麦花粉、菜花粉、玉竹、桃仁、红枣、桂圆、甘草、蛹虫草、杜仲雄花、辣 木叶、阿萨伊果,制成牛蒡精华膏;制备方法简单,将牛蒡根提取物作为主要原料,制成 牛蒡精华膏,制得的牛蒡精华膏作为口服营养剂,由于含有水解蛋黄粉,可以促进人体对 钙物质的吸收,可以提高人体免疫力以及抗病毒的能力,改善肠胃、治疗便秘、改善睡眠、 补血安神、健脑益智,还可以美容养颜、美容瘦身、抗衰老、改善暗黄肤质。
具体实施方式
下面对本发明作进一步说明。
实施例中所用原料均为常规市售产品,所用设备均为常规设备。
实施例1
一种牛蒡人参精华膏,该精华膏由以下质量百分比的原料组成:牛蒡根提取物50%、人 参浓缩液5%、复合浓缩液5%、水解蛋黄粉5%、蜂蜜5%、库拉索芦荟凝胶5%、诺丽果浆5%、 小麦低聚肽5%、圆苞车前子壳5%、壳寡糖5%、L-阿拉伯糖5%、低聚异麦芽糖8%,其中复 合浓缩液包括山药0.5%、茯苓0.4%、重瓣红玫瑰0.3%、松花粉0.2%、金银花0.2%、玉米 花粉0.22%、芝麻花粉0.5%、高粱花粉0.25%、荞麦花粉0.3%、菜花粉0.15%、玉竹0.1%、 桃仁0.25%、红枣0.5%、桂圆0.12%、甘草0.25%、蛹虫草0.1%、杜仲雄花0.4%、辣木叶 0.1%、阿萨伊果0.16%。
牛蒡根提取物通过以下步骤制得:精选二年生新鲜牛蒡根,剔除腐烂、虫蛀、霉变干 裂不合格品,将合格的牛蒡根使用前放在2℃冷库中贮存3个月,取出牛蒡根,用清水冲洗, 将洗净的牛蒡根去皮,将去皮后的牛蒡根切粒,将切粒后的牛蒡根颗粒加水预煮熬制30min, 再进行喷雾干燥做成速溶颗粒粉;牛蒡根颗粒与水的比例为1:10。
人参浓缩液通过以下步骤制得:精选人参,将精选后的人参用清水冲洗,冲洗后的人 参切片,人参片中加水按照1:10的比例,预煮熬制浓缩,浓缩至1:1的比例备用。
复合浓缩液通过以下步骤制得:按配比分别秤取山药、茯苓、重瓣红玫瑰、松花粉、金银花、玉米花粉、芝麻花粉、高粱花粉、荞麦花粉、菜花粉、玉竹、桃仁、红枣、桂圆、 甘草、蛹虫草、杜仲雄花、辣木叶、阿萨伊果,混合后加水按照1:10的比例,预煮熬制剩 余比例为1:1备用。
一种牛蒡人参精华膏的制备方法,包括以下步骤:
S1、将牛蒡根提取物、人参浓缩液、复合浓缩液混合,得到混合浓缩液;
S2、在步骤S1中的混合浓缩液中加入水解蛋黄粉、蜂蜜、库拉索芦荟凝胶、诺丽果浆、 小麦低聚肽、圆苞车前子壳、壳寡糖、L-阿拉伯糖、低聚异麦芽糖,混合后,继续熬制,直至固形物含量为70%,结束熬制,得到精华膏;
S3、将熬制好的精华膏进行热灌装后杀菌,杀菌温度为80℃,时间为25min。
实施例2
一种牛蒡人参精华膏,该精华膏由以下质量份的原料制成:牛蒡根提取物52.5%、人参 浓缩液5.5%、复合浓缩液5.5%、水解蛋黄粉5.5%、蜂蜜5.5%、库拉索芦荟凝胶5.5%、诺 丽果浆5.5%、小麦低聚肽5.5%、圆苞车前子壳5.5%、壳寡糖5.5%、L-阿拉伯糖5.5%、低 聚异麦芽糖9%,其中复合浓缩液包括山药0.52%、茯苓0.43%、重瓣红玫瑰0.33%、松花粉 0.23%、金银花0.23%、玉米花粉0.26%、芝麻花粉0.53%、高粱花粉0.28%、荞麦花粉0.33%、 菜花粉0.18%、玉竹0.13%、桃仁0.28%、红枣0.53%、桂圆0.17%、甘草0.28%、蛹虫草0.13%、 杜仲雄花0.42%、辣木叶0.13%、阿萨伊果0.19%。
牛蒡根提取物通过以下步骤制得:精选二年生新鲜牛蒡根,剔除腐烂、虫蛀、霉变干 裂不合格品,将合格的牛蒡根使用前放在2~8℃冷库中贮存4.5个月,取出牛蒡根,用清水冲洗,将洗净的牛蒡根去皮,将去皮后的牛蒡根切粒,将切粒后的牛蒡根颗粒加水预煮熬制40min,再进行喷雾干燥做成速溶颗粒粉;牛蒡根颗粒与水的比例为1:10。
人参浓缩液通过以下步骤制得:精选人参,将精选后的人参用清水冲洗,冲洗后的人 参切片,人参片中加水按照1:10的比例,预煮熬制浓缩,浓缩至1:1的比例备用。
复合浓缩液通过以下步骤制得:按配比分别秤取山药、茯苓、重瓣红玫瑰、松花粉、金银花、玉米花粉、芝麻花粉、高粱花粉、荞麦花粉、菜花粉、玉竹、桃仁、红枣、桂圆、 甘草、蛹虫草、杜仲雄花、辣木叶、阿萨伊果,混合后加水按照1:10的比例,预煮熬制剩 余比例为1:1备用。
一种牛蒡人参精华膏的制备方法,包括以下步骤:
S1、将牛蒡根提取物、人参浓缩液、复合浓缩液混合,得到混合浓缩液;
S2、在步骤S1中的混合浓缩液中加入水解蛋黄粉、蜂蜜、库拉索芦荟凝胶、诺丽果浆、 小麦低聚肽、圆苞车前子壳、壳寡糖、L-阿拉伯糖、低聚异麦芽糖,混合后,继续熬制,直至固形物含量为80%,结束熬制,得到精华膏;
S3、将熬制好的精华膏进行热灌装后杀菌,杀菌温度为85℃,时间为30min。
实施例3
一种牛蒡人参精华膏,该精华膏由以下质量百分比的原料组成:牛蒡根提取物50~55%、 人参浓缩液6%、复合浓缩液6%、水解蛋黄粉6%、蜂蜜6%、库拉索芦荟凝胶6%、诺丽果浆 6%、小麦低聚肽6%、圆苞车前子壳6%、壳寡糖6%、L-阿拉伯糖6%、低聚异麦芽糖10%,其 中复合浓缩液包括山药0.55%、茯苓0.45%、重瓣红玫瑰0.35%、松花粉0.25%、金银花0.25%、 玉米花粉0.3%、芝麻花粉0.55%、高粱花粉0.3%、荞麦花粉0.35%、菜花粉0.2%、玉竹0.15%、 桃仁0.3%、红枣0.55%、桂圆0.2%、甘草0.3%、蛹虫草0.15%、杜仲雄花0.43%、辣木叶 0.15%、阿萨伊果0.22%。
牛蒡根提取物通过以下步骤制得:精选二年生新鲜牛蒡根,剔除腐烂、虫蛀、霉变干 裂不合格品,将合格的牛蒡根使用前放在8℃冷库中贮存6个月,取出牛蒡根,用清水冲洗, 将洗净的牛蒡根去皮,将去皮后的牛蒡根切粒,将切粒后的牛蒡根颗粒加水预煮熬制50min, 再进行喷雾干燥做成速溶颗粒粉;牛蒡根颗粒与水的比例为1:10。
人参浓缩液通过以下步骤制得:精选人参,将精选后的人参用清水冲洗,冲洗后的人 参切片,人参片中加水按照1:10的比例,预煮熬制浓缩,浓缩至1:1的比例备用。
复合浓缩液通过以下步骤制得:按配比分别秤取山药、茯苓、重瓣红玫瑰、松花粉、金银花、玉米花粉、芝麻花粉、高粱花粉、荞麦花粉、菜花粉、玉竹、桃仁、红枣、桂圆、 甘草、蛹虫草、杜仲雄花、辣木叶、阿萨伊果,混合后加水按照1:10的比例,预煮熬制剩 余比例为1:1备用。
一种牛蒡人参精华膏的制备方法,包括以下步骤:
S1、将牛蒡根提取物、人参浓缩液、复合浓缩液混合,得到混合浓缩液;
S2、在步骤S1中的混合浓缩液中加入水解蛋黄粉、蜂蜜、库拉索芦荟凝胶、诺丽果浆、 小麦低聚肽、圆苞车前子壳、壳寡糖、L-阿拉伯糖、低聚异麦芽糖,混合后,继续熬制,直至固形物含量为90%,结束熬制,得到精华膏;
S3、将熬制好的精华膏进行热灌装后杀菌,杀菌温度为90℃,时间为35min。
Claims (7)
1.一种牛蒡人参精华膏,其特征在于,该精华膏由以下质量百分比的原料组成:牛蒡根提取物50~55%、人参浓缩液5~6%、复合浓缩液5~6%、水解蛋黄粉5~6%、蜂蜜5~6%、库拉索芦荟凝胶5~6%、诺丽果浆5~6%、小麦低聚肽5~6%、圆苞车前子壳5~6%、壳寡糖5~6%、L-阿拉伯糖5~6%、低聚异麦芽糖8~10%,其中复合浓缩液包括山药0.5~0.55%、茯苓0.4~0.45%、重瓣红玫瑰0.3~0.35%、松花粉0.2~0.25%、金银花0.2~0.25%、玉米花粉0.22~0.3%、芝麻花粉0.5~0.55%、高粱花粉0.25~0.3%、荞麦花粉0.3~0.35%、菜花粉0.15~0.2%、玉竹0.1~0.15%、桃仁0.25~0.3%、红枣0.5~0.55%、桂圆0.12~0.2%、甘草0.25~0.3%、蛹虫草0.1~0.15%、杜仲雄花0.4~0.43%、辣木叶0.1~0.15%、阿萨伊果0.16~0.22%。
2.根据权利要求1所述的一种牛蒡人参精华膏,其特征在于,该精华膏由以下质量份的原料制成:牛蒡根提取物52.5%、人参浓缩液5.5%、复合浓缩液5.5%、水解蛋黄粉5.5%、蜂蜜5.5%、库拉索芦荟凝胶5.5%、诺丽果浆5.5%、小麦低聚肽5.5%、圆苞车前子壳5.5%、壳寡糖5.5%、L-阿拉伯糖5.5%、低聚异麦芽糖9%,其中复合浓缩液包括山药0.52%、茯苓0.43%、重瓣红玫瑰0.33%、松花粉0.23%、金银花0.23%、玉米花粉0.26%、芝麻花粉0.53%、高粱花粉0.28%、荞麦花粉0.33%、菜花粉0.18%、玉竹0.13%、桃仁0.28%、红枣0.53%、桂圆0.17%、甘草0.28%、蛹虫草0.13%、杜仲雄花0.42%、辣木叶0.13%、阿萨伊果0.19%。
3.根据权利要求1或2所述的一种牛蒡人参精华膏,其特征在于,牛蒡根提取物通过以下步骤制得:精选二年生新鲜牛蒡根,剔除腐烂、虫蛀、霉变干裂不合格品,将合格的牛蒡根使用前放在2~8℃冷库中贮存3~6个月,取出牛蒡根,用清水冲洗,将洗净的牛蒡根去皮,将去皮后的牛蒡根切粒,将切粒后的牛蒡根颗粒加水预煮熬制30~50min,再进行喷雾干燥做成速溶颗粒粉。
4.根据权利要求3所述的一种牛蒡人参精华膏,其特征在于,牛蒡根颗粒与水的比例为1:10。
5.根据权利要求1或2所述的一种牛蒡人参精华膏,其特征在于,人参浓缩液通过以下步骤制得:精选人参,将精选后的人参用清水冲洗,冲洗后的人参切片,人参片中加水按照1:10的比例,预煮熬制浓缩,浓缩至1:1的比例备用。
6.根据权利要求1或2所述的一种牛蒡人参精华膏,其特征在于,复合浓缩液通过以下步骤制得:按配比分别秤取山药、茯苓、重瓣红玫瑰、松花粉、金银花、玉米花粉、芝麻花粉、高粱花粉、荞麦花粉、菜花粉、玉竹、桃仁、红枣、桂圆、甘草、蛹虫草、杜仲雄花、辣木叶、阿萨伊果,混合后加水按照1:10的比例,预煮熬制剩余比例为1:1备用。
7.一种上述牛蒡人参精华膏的制备方法,其特征在于,包括以下步骤:
S1、将牛蒡根提取物、人参浓缩液、复合浓缩液混合,得到混合浓缩液;
S2、在步骤S1中的混合浓缩液中加入水解蛋黄粉、蜂蜜、库拉索芦荟凝胶、诺丽果浆、小麦低聚肽、圆苞车前子壳、壳寡糖、L-阿拉伯糖、低聚异麦芽糖,混合后,继续熬制,直至固形物含量为70~90%,结束熬制,得到精华膏;
S3、将熬制好的精华膏进行热灌装后杀菌,杀菌温度为80~90℃,时间为25~35min。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911037297.8A CN110679935A (zh) | 2019-10-29 | 2019-10-29 | 一种牛蒡人参精华膏及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911037297.8A CN110679935A (zh) | 2019-10-29 | 2019-10-29 | 一种牛蒡人参精华膏及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110679935A true CN110679935A (zh) | 2020-01-14 |
Family
ID=69114500
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911037297.8A Pending CN110679935A (zh) | 2019-10-29 | 2019-10-29 | 一种牛蒡人参精华膏及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110679935A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115708573A (zh) * | 2022-12-27 | 2023-02-24 | 天益食品(徐州)有限公司 | 一种dha多维营养牛蒡果冻及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101254228A (zh) * | 2008-03-20 | 2008-09-03 | 朱惠芬 | 一种滋阴壮阳牛蒡元素的制备方法 |
CN103349119A (zh) * | 2013-07-07 | 2013-10-16 | 安徽世茂中药股份有限公司 | 一种八宝茶及其制备方法 |
CN108056345A (zh) * | 2017-12-22 | 2018-05-22 | 天益食品(徐州)有限公司 | 一种牛蒡复合饮料及其制备方法 |
CN109601993A (zh) * | 2017-09-30 | 2019-04-12 | 时传彬 | 一种补肾益气养血安神滋补膏及其制备工艺 |
-
2019
- 2019-10-29 CN CN201911037297.8A patent/CN110679935A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101254228A (zh) * | 2008-03-20 | 2008-09-03 | 朱惠芬 | 一种滋阴壮阳牛蒡元素的制备方法 |
CN103349119A (zh) * | 2013-07-07 | 2013-10-16 | 安徽世茂中药股份有限公司 | 一种八宝茶及其制备方法 |
CN109601993A (zh) * | 2017-09-30 | 2019-04-12 | 时传彬 | 一种补肾益气养血安神滋补膏及其制备工艺 |
CN108056345A (zh) * | 2017-12-22 | 2018-05-22 | 天益食品(徐州)有限公司 | 一种牛蒡复合饮料及其制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115708573A (zh) * | 2022-12-27 | 2023-02-24 | 天益食品(徐州)有限公司 | 一种dha多维营养牛蒡果冻及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101090284B1 (ko) | 홍삼과 녹용 추출물을 포함하는 드링크제 및 그의 제조방법 | |
KR101541516B1 (ko) | 누에와 뽕나무잎과 상지(桑枝)를 주원료로한 이온미네랄 건강음료의 제조방법 | |
CN106860680A (zh) | 金花人参压片糖果及其制备方法 | |
CN103719948A (zh) | 一种健脾开胃药膳猪肚汤 | |
CN106858215A (zh) | 一种百香果复合饮料 | |
CN106937741A (zh) | 一种脱脂亚麻籽粉防癌抗癌健康减肥法及其制备方法 | |
CN103652926A (zh) | 肿瘤病人食品组合物 | |
CN106070626A (zh) | 酸马奶水果饮料及其制备方法 | |
KR20090127970A (ko) | 생식환의 조성물 및 이의 제조 방법 | |
KR20160032851A (ko) | 흰점박이 꽃무지를 주재료로 하는 환의 제조방법 | |
KR101999675B1 (ko) | 관상동맥성 심장질환의 예방과 치료용 생약조성물 | |
CN103749782A (zh) | 一种金花火麻养生茶 | |
CN105249440A (zh) | 一种阿胶糕 | |
CN102511876B (zh) | 山楂红枣浓浆及其生产工艺 | |
CN110679935A (zh) | 一种牛蒡人参精华膏及其制备方法 | |
CN109527577A (zh) | 一种具有解酒护肝功能的组合物 | |
KR101227063B1 (ko) | 혈액순환 개선용 식품 조성물 및 그 제조방법 | |
CN101991110A (zh) | 野生灵芝系列食品 | |
KR102702964B1 (ko) | 복합효소를 사용한 발효 저분자 콜라겐 및 그 제조방법 | |
CN109730222A (zh) | 酵素复合液及其保健饮料 | |
CN114748583A (zh) | 一种滋补养生的中药药酒 | |
CN102511868A (zh) | 一种添加维生素的红枣阿胶浓浆 | |
CN110584037A (zh) | 一种食品人参膏及其制备方法 | |
KR20210041387A (ko) | 갈화 추출물 및 차전자피 분말을 함유한 숙취해소용 천연차 및 그 제조방법 | |
KR102728913B1 (ko) | 음용성이 증진되도록 구성되는 사물탕 성분을 포함하는 건강 보조식품 및 그의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200114 |